BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4028000)

  • 1. Combination chemotherapy in vitro exploiting glutamine metabolism of human glioma and medulloblastoma.
    Dranoff G; Elion GB; Friedman HS; Bigner DD
    Cancer Res; 1985 Sep; 45(9):4082-6. PubMed ID: 4028000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of glutamine on the growth of human glioma and medulloblastoma in culture.
    Dranoff G; Elion GB; Friedman HS; Campbell GL; Bigner DD
    Cancer Res; 1985 Sep; 45(9):4077-81. PubMed ID: 2862994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of antitumor activity of glutamine antagonists 6-diazo-5-oxo-L-norleucine and acivicin in cell culture by glutaminase-asparaginase.
    Rosenfeld H; Roberts J
    Cancer Res; 1981 Apr; 41(4):1324-8. PubMed ID: 7214322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies.
    Hidalgo M; Rodriguez G; Kuhn JG; Brown T; Weiss G; MacGovren JP; Von Hoff DD; Rowinsky EK
    Clin Cancer Res; 1998 Nov; 4(11):2763-70. PubMed ID: 9829740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of human glioma and medulloblastoma tumor lines in athymic mice with diaziquone and diaziquone-based drug combinations.
    Schold SC; Friedman HS; Bjornsson TD; Bigner DD
    Cancer Res; 1984 Jun; 44(6):2352-7. PubMed ID: 6722774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Asparaginase
    Sanghez V; Chen M; Li S; Chou TF; Iacovino M; Lin HJ; Lasky JL; Panosyan EH
    Anticancer Res; 2018 May; 38(5):2627-2634. PubMed ID: 29715082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the sensitivity of human colon cancer cells to growth inhibition by acivicin achieved through inhibition of nucleic acid precursor salvage by dipyridamole.
    Fischer PH; Pamukcu R; Bittner G; Willson JK
    Cancer Res; 1984 Aug; 44(8):3355-9. PubMed ID: 6744269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of tumor growth-inhibiting protein by the neonatal mouse brain: dependence on intracellular glutamine metabolism.
    Miwa N; Matsuno T; Mizuno S
    J Cell Physiol; 1987 Sep; 132(3):538-44. PubMed ID: 3654765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MCNU effectiveness on brain tumor. Part I: Antitumor activity in vitro on human glioma and neuroblastoma cell lines].
    Wakabayashi T; Yoshida J; Inoue I; Kageyama N; Nagata M; Kanzaki M
    Gan To Kagaku Ryoho; 1984 May; 11(5):1098-106. PubMed ID: 6586113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy.
    Geoerger B; Kerr K; Tang CB; Fung KM; Powell B; Sutton LN; Phillips PC; Janss AJ
    Cancer Res; 2001 Feb; 61(4):1527-32. PubMed ID: 11245461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of glutamine antimetabolites 6-diazo-5-oxo-L-norleucine (DON) and acivicin in sensitive and resistant tumor cell lines.
    Huber KR; Rosenfeld H; Roberts J
    Int J Cancer; 1988 May; 41(5):752-5. PubMed ID: 3366493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acivicin and dipyridamole on hepatoma 3924A cells.
    Zhen YS; Lui MS; Weber G
    Cancer Res; 1983 Apr; 43(4):1616-9. PubMed ID: 6831407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model.
    Slagel DE; Feola J; Houchens DP; Ovejera AA
    Cancer Res; 1982 Mar; 42(3):812-6. PubMed ID: 7059979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines.
    Bjelogrlić SK; Srdić T; Radulović S
    J BUON; 2007; 12(1):71-6. PubMed ID: 17436405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibition of glutamine synthetase sensitizes human sarcoma cells to L-asparaginase.
    Tardito S; Uggeri J; Bozzetti C; Bianchi MG; Rotoli BM; Franchi-Gazzola R; Gazzola GC; Gatti R; Bussolati O
    Cancer Chemother Pharmacol; 2007 Oct; 60(5):751-8. PubMed ID: 17256128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 6-diazo-5-oxo-L-norleucine (DON) on human carcinoid tumor cell aggregates.
    Wu F; Bergström M; Stridsberg M; Orlefors H; Eriksson B; Oberg K; Watanabe Y; Långstrom B
    Anticancer Res; 1997; 17(4A):2363-7. PubMed ID: 9252648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Glutamine Antagonist JHU395 Suppresses MYC-Driven Medulloblastoma Growth and Induces Apoptosis.
    Pham K; Maxwell MJ; Sweeney H; Alt J; Rais R; Eberhart CG; Slusher BS; Raabe EH
    J Neuropathol Exp Neurol; 2021 Mar; 80(4):336-344. PubMed ID: 33712838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of fluoropyrimidine-resistant murine leukemic cell lines by one-step mutation and selection.
    Mulkins MA; Heidelberger C
    Cancer Res; 1982 Mar; 42(3):956-64. PubMed ID: 6460554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.